Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 3/20 | 0.56 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23347584 | 0.98 | LPL (0.57) | LPLLIPGTDP1L3MBTL1PPARG | |
| SCHEMBL5599314 | 0.98 | LPL (0.57) | LPLLIPGTDP1L3MBTL1PPARG | |
| SCHEMBL4194332 | 0.94 | LPL (0.49) | LPLLIPGIDO1 | |
| SCHEMBL30138668 | 0.94 | LPL (0.49) | LPLLIPGIDO1 | |
| SCHEMBL8661179 | 0.86 | LPL (0.50) | LPLLIPGPPARGPPARA | |
| SCHEMBL4190473 | 0.85 | IDO1 (0.50) | LPLLIPGIDO1 | |
| SCHEMBL8518305 | 0.85 | LPL (0.66) | LPLLIPGTDP1L3MBTL1PPARG | |
| SCHEMBL5241784 | 0.85 | IDO1 (0.54) | IDO1 | |
| SCHEMBL4032533 | 0.83 | LPL (0.67) | LPLLIPGPPARGPPARA | |
| SCHEMBL5249436 | 0.83 | LPL (0.67) | LPLLIPGPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114716296-B | Efficient halogenation synthesis method of alkyl halide | 润药仁智(北京)科技有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-114716296-A | Efficient halogenation synthesis method of alkyl halide | 北京大学 | 2022-07-08 | — | — | CN | disclosed |
| EP-3374028-B1 | SPHINGAMIDE COMPOUNDS AND METHODS FOR BINDING INKT CELLS | LA JOLLA INST ALLERGY & IMMUNOLOGY (US) | 2021-05-26 | — | — | EP | disclosed |
| US-8703798-B2 | Antifungal and antiparasitic indoloquinoline derivatives | FLORIDA A&M UNIVERSITY (US) | 2014-04-22 | — | — | US | disclosed |
| US-20120157493-A1 | Antifungal and Antiparasitic Indoloquinoline Derivatives | FLORIDA A&M UNIVERSITY (US) | 2012-06-21 | — | — | US | disclosed |
| US-8158646-B2 | Antifungal and antiparasitic indoloquinoline derivates | FLORIDA AGRICULTURAL AND MECHANICAL UNIVERSITY (US) | 2012-04-17 | — | — | US | disclosed |
| WO-2007123732-A2 | ANTIFUNGAL AND ANTIPARASITIC INDOLOQUINOLINE DERIVATIVES | FLORIDA A & M UNIVERSITY (US) | 2007-11-01 | — | — | WO | disclosed |
| US-20070232640-A1 | Antifungal and antiparasitic indoloquinoline derivates | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157493-A1 | Antifungal and Antiparasitic Indoloquinoline Derivatives | IDO1, IDO2, IMMT | LPL 4340/4885LIPG 4546/4885TDP1 2495/4885 |
| US-20070232640-A1 | Antifungal and antiparasitic indoloquinoline derivates | ARG1, ARG2, IMMT | LPL 4790/4885LIPG 4827/4885TDP1 2717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.